Universal Maritime Solutions, also called Unimed, announced on February 9 the acquisition of Regenboog Shipping Pharmacy. Unimed is backed by ZCG Private Equity, the private equity arm of ZCG, a privately held global firm.
Based in Rotterdam, Netherlands, Regenboog Shipping Pharmacy has been a distributor of pharmaceutical products and medical devices to the maritime industry since 1989. The business serves more than 300 customers, including ship managers, ship chandlers and individual vessels operating globally.
Universal Maritime Solutions is a global provider of medical and compliance solutions to the maritime industry. The company specializes in the delivery of integrated medical equipment and supplies, healthcare services and safety supply chain logistical solutions to clients worldwide.
The transaction reflects Unimed’s broader strategy under ZCG ownership to pursue targeted, locally focused acquisitions that enhance regional coverage and access to operational resources while supporting long-term platform development. Financial terms of the deal were not disclosed.
“This acquisition represents an important step in our growth strategy, strengthens Unimed’s presence in the Netherlands and builds on the company’s recent acquisition of Lagaay Medical Group, further expanding Unimed’s scale and capabilities in a core European market,” said Adam Pang, Chief Revenue Officer of Unimed.
According to data captured in the LevinPro HC database, this transaction marks the seventh healthcare product distributor acquisition announced in 2026, so far. Other acquirers in the space this year include BioSyent, NorgesGruppen, Morris & Dickson, Dental Holding, Liss Capital Partners and Asker Healthcare Group. There were 38 healthcare product distributor deals announced throughout all of 2025, and 30 announced in 2024.
